These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27757545)

  • 1. Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.
    Rashid I; Moiré N; Héraut B; Dimier-Poisson I; Mévélec MN
    Med Microbiol Immunol; 2017 Feb; 206(1):53-62. PubMed ID: 27757545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.
    Rashid I; Hedhli D; Moiré N; Pierre J; Debierre-Grockiego F; Dimier-Poisson I; Mévélec MN
    Vaccine; 2011 Nov; 29(48):8838-46. PubMed ID: 21983362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18.
    Yuan ZG; Zhang XX; Lin RQ; Petersen E; He S; Yu M; He XH; Zhou DH; He Y; Li HX; Liao M; Zhu XQ
    Vaccine; 2011 Sep; 29(38):6614-9. PubMed ID: 21762755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunisation of the recombinant Toxoplasma gondii receptor for activated C kinase 1 partly protects mice against T. gondii infection.
    Wang HL; Pang M; Yin LT; Zhang JH; Meng XL; Yu BF; Guo R; Bai JZ; Zheng GP; Yin GR
    Acta Trop; 2014 Sep; 137():58-66. PubMed ID: 24813415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice.
    Zhu YC; He Y; Liu JF; Chen J
    Parasite; 2020; 27():26. PubMed ID: 32315596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re.
    Qu D; Han J; Du A
    Exp Parasitol; 2013 Oct; 135(2):234-9. PubMed ID: 23896123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes.
    Wang T; Yin H; Li Y; Zhao L; Sun X; Cong H
    Parasite; 2017; 24():12. PubMed ID: 28367800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.
    Grzybowski MM; Dziadek B; Gatkowska JM; Dzitko K; Długońska H
    Parasitol Res; 2015 Dec; 114(12):4553-63. PubMed ID: 26337271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.
    Li XZ; Wang XH; Xia LJ; Weng YB; Hernandez JA; Tu LQ; Li LT; Li SJ; Yuan ZG
    BMC Infect Dis; 2015 Mar; 15():114. PubMed ID: 25886737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-efficacy of DNA vaccines encoding PLP1 and ROP18 against experimental Toxoplasma gondii infection in mice.
    Chen Y; Yu M; Hemandez JA; Li J; Yuan ZG; Yan H
    Exp Parasitol; 2018 May; 188():73-78. PubMed ID: 29626423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
    Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
    Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice.
    Wang HL; Wang YJ; Pei YJ; Bai JZ; Yin LT; Guo R; Yin GR
    Parasite; 2016; 23():4. PubMed ID: 26842927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a DNA vaccine encoding Toxoplasma gondii ROP54 induces protective immunity against toxoplasmosis in mice.
    Yang WB; Zhou DH; Zou Y; Chen K; Liu Q; Wang JL; Zhu XQ; Zhao GH
    Acta Trop; 2017 Dec; 176():427-432. PubMed ID: 28935555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice.
    Chen J; Li ZY; Huang SY; Petersen E; Song HQ; Zhou DH; Zhu XQ
    BMC Infect Dis; 2014 Sep; 14():487. PubMed ID: 25192845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice.
    Zhang NZ; Xu Y; Wang M; Petersen E; Chen J; Huang SY; Zhu XQ
    Expert Rev Vaccines; 2015; 14(9):1289-97. PubMed ID: 26111968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.